WHO advises 2 monoclonal antibodies for severe COVID

Jul 06, 2021

Study finds that tocilizumab and sarilumab reduce the risk of death and the need for mechanical ventilation.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top